In 2023, CuresDev nearly came to a halt. We didn’t have a clear monetization strategy. But I forged on with the hopes of finding a business model once we sign up a few customers. There was clear demand for PALIND and Prevalence Dashboard from patient organizations, but unfortunately, the business model did not exist.
A deal to acquire CuresDev fell through after several rounds of conversations. My attempts to raise money through grants and other investment routes didn't work out. I have now run out of money. It is with a heavy heart that I am writing to let you know that the CuresDev company is shutting down.
I have devoted 2 years to make CuresDev possible, and I did not make this decision lightly. I personally know the importance of this software to you and the rare disease ecosystem. So I made the entire software free, public, and open source. It is available for anyone to install and use.
I am deeply grateful for your support. Starting a company is a difficult and lonely journey. Your support made it less difficult and less lonely.
Thank you.
Sorry to hear this, Sanath.